Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation

Journal of Virology

Volumn 77, Issue 7, 2003, Pages 4127-4138

  Sawtell, N M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HYPERTHERMIA; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STRESS; TRIGEMINUS GANGLION; VIROGENESIS; VIRUS INHIBITION; VIRUS LATENCY; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MALE; MICE; NERVOUS SYSTEM DISEASES; TIME FACTORS; TRIGEMINAL GANGLION; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 0037378461     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.7.4127-4138.2003     Document Type: Article

References (54)

1. Bauer, D., and R. Tampe. 2002. Herpes viral proteins blocking the transporter associated with antigen processing TAP: from genes to function and structure. Curr. Top. Microbiol. Immunol. 269:87-99.
2. Blue, W. T., R. D. Winland, D. G. Stobbs, D. F. Kirksey, and R. E. Savage, 1981. Effects of adenosine monophosphate on the reactivation of latent herpes simplex virus type 1 infections of mice. Antimicrob. Agents Chemother. 20:547-548.
3. Blyth, W. A., T. J. Hill, H. J. Field, and D. A. Harbour, 1976. Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J. Gen. Virol. 33:547-550.
4. Card, J. P., P. Levitt, and L. W. Enquist. 1998. Different patterns of neuronal infection after intracerebral injection of two strains of pseudorabies virus. J. Virol. 72:4434-4441.
5. Dent, J. A., A. G. Poison, and M. W. Klymkowsky. 1989. A whole-mount immunocytochemical analysis of the expression of the intermediate filament protein vimentin in Xenopus. Development 105:61-74.
6. Fawl, R. L., and B. Roizman. 1993. Induction of reactivation of herpes simplex virus in murine sensory ganglia in vivo by cadmium. J. Virol. 67:7025-7031.
7. Feldman, L. T., A. R. Ellison, C. C. Voytek, L. Yang, P. Krause, and T. P. Margolis. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. USA 99:978-983.
8. Fields, B. N., D. M. Knipe, and P. M. Howley. 1996. Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
9. Gesser, R. M., and S. C. Koo. 1996. Oral inoculation with herpes simplex virus type 1 infects enteric neuron and mucosal nerve fibers within the gastrointestinal tract in mice. J. Virol. 70:4097-4102.
10. Gesser, R. M., T. Valyi-Nagy, N. W. Fraser, and S. M. Altschuler. 1995. Oral inoculation of SCID mice with an attenuated herpes simplex virus-1 strain causes persistent enteric nervous system infection and gastric ulcers without direct mucosal infection. Lab. Investig. 73:880-889.
11. Hill, T. J., W. A. Blyth, and D. A. Harbour. 1982. Recurrent herpes simplex in mice: topical treatment with acyclovir cream. Antiviral Res. 2:135-146.
12. Hill, T. J., W. A. Blyth, and D. A. Harbour. 1978. Trauma to the skin causes recurrence of herpes simplex in the mouse. J. Gen. Virol. 39:21-28.
13. Keadle, T. L., K. A. Laycock, J. K. Miller, K. K. Hook, E. D. Fenoglio, M. Francotte, M. Slaoui, P. M. Stuart, and J. S. Pepose. 1997. Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice. J. Infect. Dis. 176:331-338.
14. Keadle, T. L., L. A. Morrison, J. L. Morris, J. S. Pepose, and P. M. Stuart. 2002. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection. J. Virol. 76:3615-3625.
15. Klymkowsky M. W., and J. Hanken. 1991. Whole-mount staining of Xenopus and other vertebrates. Methods Cell Biol. 36:419-441.
16. Lachmann, R. H., M. Sadarangani, H. R. Atkinson, and S. Efstathiou. 1999. An analysis of herpes simplex virus gene expression during latency establishment and reactivation. J. Gen. Virol. 80:1271-1282.
17. Larsson, L.-I. 1988. Immunocytochemistry: theory and practice. CRC Press, Inc., Boca Raton, Fla.
18. Laycock, K. A., S. F. Lee, R. H. Brady, and J. S. Pepose. 1991. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Investig. Ophthalmol. Vis. Sci. 32:2741-2746.
19. Leib, D. A. 2002. Counteraction of interferon-induced antiviral responses by herpes simplex viruses. Curr. Top. Microbiol. Immunol. 269:171-185.
20. Liu, T., K. M. Khanna, B. N. Carriere, and R. L. Hendricks. 2001. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75:11178-11184.
21. + T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191:1459-1466.
22. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:264-271.
23. Loiacono, C. M., R. Myers, and W. J. Mitchell. 2002. Neurons differentially activate the herpes simplex virus type 1 immediate-early gene ICPO and ICP27 promoters in transgenic mice. J. Virol. 76:2449-2459.
24. Lubinski, J. M., M. Jiang, L. Hook, Y. Chang, C. Sarver, D. Mastellos, J. D. Lambris, G. H. Cohen, R. J. Eisenberg, and H. M. Friedman. 2002. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J. Virol. 76:9232-9241.
25. Luque, J. M., W. B. Adams, and J. G. Nicholls. 1998. Procedures for wholemount immunohistochemistry and in situ hybridization of immature mammalian CNS. Brain Res. Brain Res. Protoc. 2:165-173.
26. Margolis, T. P., F. Sedarati, A. T. Dobson, L. T. Feldman, and J. G. Stevens. 1992. Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology 189:150-160.
27. McKay Hart, A., T. Brannstrom, M. Wiberg, and G. Terenghi. 2002. Primary sensory neurons and satellite cells after peripheral axotomy in the adult rat: time course of cell death and elimination. Exp. Brain Res. 142:308-318.
28. Mester, J. C., T. A. Twomey, E. T. Tepe, and D. I. Bernstein. 1999. Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C. Vaccine 18:875-883.
29. Mitchell, W. J., P. Gressens, J. R. Martin, and R. DeSanto. 1994. Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J. Gen. Virol. 75:1201-1210.
30. Nesburn, A. B., R. L. Burke, H. Ghiasi, S. M. Slanina, and S. L. Wechsler. 1998. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease. Investig. Ophthalmol. Vis. Sci. 39:1163-1170.
31. Preston, C. M. 2000. Repression of viral transcription during herpes simplex virus latency. J. Gen. Virol. 81:1-19.
32. Ramakrishnan, R., P. L. Poliani, M. Levine, J. C. Glorioso, and D. J. Fink. 1996. Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J. Virol. 70:6519-6523.
33. Sawtell, N. M. 1997. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J. Virol. 71:5423-5431.
34. Sawtell, N. M. 1998. The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol. 72:6888-6892.
35. Sawtell, N. M., D. I. Bernstein, and L. R. Stanberry. 1999. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia. J. Infect. Dis. 180:821-823.
36. Sawtell, N. M., D. K. Poon, C. S. Tansky, and R. L. Thompson. 1998. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J. Virol. 72:5343-5350.
37. Sawtell, N. M., and R. L. Thompson. 1992. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 66:2157-2169.
38. Sawtell, N. M., and R. L. Thompson. 1992. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. 66:2150-2156.
39. Sawtell, N. M., R. L. Thompson, L. R. Stanberry, and D. I. Bernstein. 2001. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. J. Infect. Dis. 184:964-971.
40. Shimeld, C., D. L. Easty, and T. J. Hill. 1999. Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and cytokines. J. Virol. 73:1767-1773.
41. Shimeld, C., S. Efstathiou, and T. Hill. 2001. Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection. J. Virol. 75:5252-5262.
42. Shimeld, C., S. J. Lewkowicz-Moss, K. M. Lipworth, T. J. Hill, W. A. Blyth, and D. L. Easty. 1986. Antigens of herpes simplex virus in whole corneal epithelial sheets from mice. Arch. Ophthalmol. 104:1830-1834.
43. Shimeld, C., J. L. Whiteland, S. M. Nicholls, E. Grinfeld, D. L. Easty, H. Gao, and T. J. Hill. 1995. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61:7-16.
44. Shimeld, C., J. L. Whiteland, N. A. Williams, D. L. Easty, and T. J. Hill. 1996. Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and immune cell infiltration. J. Gen. Virol. 77:2583-2590.
45. Speck, P. G., and A. Simmons. 1991. Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1. J. Virol. 65:4001-4005.
46. Spivack, J. G., and N. W. Fraser. 1987. Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J. Virol. 61:3841-3847.
47. Stanberry, L. R., R. Burke, and M. G. Myers. 1988. Herpes simplex virus glycoprotein treatment of recurrent genital herpes. J. Infect. Dis. 157:156-163.
48. Stanberry, L. R., C. J. Harrison, D. I. Bernstein, R. L. Burke, R. Shukla, G. Ott, and M. G. Myers. 1989. Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: factors influencing efficacy. Antiviral Res. 11:203-214.
49. Steiner, I., N. Mador, I. Reibstein, J. G. Spivack, and N. W. Fraser. 1994. Herpes simplex virus type 1 gene expression and reactivation of latent infection in the central nervous system. Neuropathol. Appl. Neurobiol. 20:253-260.
50. Stevens, J. G., and M. L. Cook. 1971. Latent herpes simplex virus in spinal ganglia of mice. Science 173:843-845.
51. Tautz, D., and C. Pfeifle. 1989. A non-radioactive in situ hybridization method for the localization of specific RNAs in Drosophila embryos reveals translational control of the segmentation gene hunchback. Chromosoma 98:81-85.
52. Thompson, R. L., and N. M. Sawtell. 1997. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol. 71:5432-5440.
53. Tullo, A. B., C. Shimeld, W. A. Blyth, T. J. Hill, and D. L. Easty. 1982. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J. Gen. Virol. 63:95-101.
54. Weishaupt, J. H., and M. Bahr. 2001. Degeneration of axotomized retinal ganglion cells as a model for neuronal apoptosis in the central nervous system: molecular death and survival pathways. Restor. Neurol. Neurosci. 19:19-27.